Dave Clapp sets £250m three-year target for MVP and Ataraxia

Dave Clapp, CEO of MVP and Ataraxia

Dave Clapp, CEO of Minority Venture Partners and Ataraxia, has unveiled a £250m gross written premium target for the broker investment group over the next three years.

When Clapp came on board last year, as revealed by Insurance Age, the business had 26 investments and in the region of £120m of GWP. This has now grown to 30 and just shy of £150m he calculated as he accepted the three-year goal was “very ambitious”.

The group will have to do “around £35m of new deals a year” to reach the target and is on track this year with eight going through the legal process at the moment, he noted.

The target market for Ataraxia stands at around £2m to £5m of GWP with

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@insuranceage.co.uk.

You are currently unable to copy this content. Please contact info@insuranceage.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Age? View our subscription options

Register

Sign up and gain access to five complimentary news articles every month.

Already have an account? Sign in here

This address will be used to create your account

You need to sign in to use this feature. If you don’t have an Insurance Age account, please register now.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: